GH secretagogues act centrally on hypothalamic neurons and require an intact GHRH system for potent in vivo activity, though they can release GH directly from the pituitary independently.
GHRH system requiredGH secretagogues need intact hypothalamic GHRH pathways for full in vivo activity despite direct pituitary effects
What the researchers found
GH secretagogues activate hypothalamic neurons and require an intact GHRH system for full in vivo potency, despite being able to release GH directly from the pituitary.
Why it matters
Understanding that GHRPs need a working GHRH system explains why they're less effective in conditions where GHRH neurons are damaged or absent.
How the study worked
Review of preclinical evidence from normal and transgenic animal models on hypothalamic targets and neural circuits activated by GH secretagogues.
What this study cannot tell us
Review based primarily on animal models. Human hypothalamic-pituitary dynamics may differ.
How to read the evidence
Moderate evidence from a comprehensive review of normal and transgenic animal models.
When this study was published
Published in 1997, establishing key principles about GH secretagogue hypothalamic dependence.
The bigger picture
This dependency on GHRH integrity explains clinical observations that GHRPs are less effective in patients with hypothalamic damage compared to those with pituitary-level GH deficiency.
Questions still open
- Can patients with hypothalamic GHRH damage still respond to GH secretagogues?
- Could GHRH co-administration restore GH secretagogue efficacy in GHRH-deficient patients?
Common questions
Why do GHRPs need GHRH to work well?
Who might not respond well to GHRPs?
Read the original research
Hypothalamic targets for growth hormone secretagogues.
Acta paediatrica (Oslo, Norway : 1992). Supplement, 423, 88-91
Citation
Robinson, I C. (1997). Hypothalamic targets for growth hormone secretagogues.. Acta paediatrica (Oslo, Norway : 1992). Supplement, 423, 88-91.